These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 26840339)

  • 1. Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions.
    Clouse BJ; Jadcherla SR; Slaughter JL
    PLoS One; 2016; 11(2):e0148188. PubMed ID: 26840339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD002311. PubMed ID: 36521169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews.
    van de Loo M; van Kaam A; Offringa M; Doyle LW; Cooper C; Onland W
    Cochrane Database Syst Rev; 2024 Apr; 4(4):CD013271. PubMed ID: 38597338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
    Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
    JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD002311. PubMed ID: 28836266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis.
    Hay S; Ovelman C; Zupancic JA; Doyle LW; Onland W; Konstantinidis M; Shah PS; Soll R
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD013730. PubMed ID: 37650547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001146. PubMed ID: 34674229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled Drugs and Systemic Corticosteroids for Bronchopulmonary Dysplasia.
    Bassler D; van den Anker J
    Pediatr Clin North Am; 2017 Dec; 64(6):1355-1367. PubMed ID: 29173790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled Corticosteroid Exposure in Hospitalized Infants with Bronchopulmonary Dysplasia.
    Leiting C; Kerns E; Euteneuer JC; McCulloh RJ; Peeples ES
    Am J Perinatol; 2024 May; 41(S 01):e85-e93. PubMed ID: 35523409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled drugs for the prevention and treatment of bronchopulmonary dysplasia.
    Pantalitschka T; Poets CF
    Pediatr Pulmonol; 2006 Aug; 41(8):703-8. PubMed ID: 16779858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2012 Apr; (4):CD002311. PubMed ID: 22513906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2007 Oct; (4):CD002057. PubMed ID: 17943765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchopulmonary dysplasia: Myths of pharmacologic management.
    Donn SM
    Semin Fetal Neonatal Med; 2017 Oct; 22(5):354-358. PubMed ID: 28807545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug therapies in bronchopulmonary dysplasia: debunking the myths.
    Tin W; Wiswell TE
    Semin Fetal Neonatal Med; 2009 Dec; 14(6):383-90. PubMed ID: 19747890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of inhaled corticosteroids for infants with bronchopulmonary dysplasia.
    Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR
    PLoS One; 2014; 9(9):e106838. PubMed ID: 25192252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
    Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y
    Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2012 May; (5):CD002057. PubMed ID: 22592682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.